小于2岁婴幼儿乳房早发育临床随访研究

王应旻; 梁黎; 方燕兰; 傅君芬; 董关萍; 王春林

doi:10.7499/j.issn.1008-8830.2013.04.010

PDF(896 KB)

中国当代儿科杂志 ›› 2013, Vol. 15 ›› Issue (4) : 285-288. DOI: 10.7499/j.issn.1008-8830.2013.04.010

论著·临床研究

小于2岁婴幼儿乳房早发育临床随访研究

王应旻，梁黎，方燕兰，傅君芬，董关萍，王春林

作者信息 +

A clinical follow-up study of premature thelarche in infants under two years of age

WANG Ying-Min, LIANG Li, FANG Yan-Lan, FU Jun-Fen, DONG Guan-Ping, WANG Chun-Lin

Author information +

文章历史 +

摘要

目的：了解小于2岁婴幼儿乳房发育的临床现况及转归，分析影响乳房消退的相关因素。方法：分析2009年10月至2010年9月间因乳房早发育来我院内分泌科就诊的863例2岁以下患儿临床及实验诊断资料并进行纵向随访研究。结果：小于2岁单纯乳房早发育患儿中绝大多数（89.3%）在3周岁内消退，乳房消退平均年龄为17±6月龄；小部分（10.7%）反复或持续增大，3岁后仍不消退，极少数转变为中枢性性早熟。初诊时乳房Tanner分期和基础E2值升高与否是影响乳房消退的独立危险因素。结论：小于2岁婴幼儿乳房早发育在临床并不少见，大多呈自限性病程，3周岁内可消退，但对2岁以上乳房增大持续不消退者要定期随访。

Abstract

OBJECTIVE: To investigate the clinical status and natural course of premature thelarche (PT) in infants under 2 years of age and to analyze the predictive factors for regression of thelarche. METHODS: The clinical and laboratory data of 863 infants under 2 years of age, who visited the department of endocrinology in our hospital due to PT between October 2009 and September 2010, were analyzed. A a longitudinal follow-up study was performed. RESULTS: Of the infants under 2 years of age with isolated PT, 89.3% showed a regression before the age of 3 years (mean 17±5.6 months), 10.7% had recurrent or persistent thelarche, with no regression after the age of 3 years, and some even developed into central precocious puberty. The independent predictive factors for regression of thelarche were Tanner stage at the first visit and whether baseline estradiol level had increased. CONCLUSIONS: PT in infants under 2 years of age is not rare in the clinical setting, and it usually runs a self-limited course, subsiding before the age of 3 years. However, regular follow-ups should be performed for infants aged over 2 years with persistent thelarche.

导出引用

王应旻，梁黎，方燕兰，傅君芬，董关萍，王春林. 小于2岁婴幼儿乳房早发育临床随访研究[J]. 中国当代儿科杂志. 2013, 15(4): 285-288 https://doi.org/10.7499/j.issn.1008-8830.2013.04.010

WANG Ying-Min, LIANG Li, FANG Yan-Lan, FU Jun-Fen, DONG Guan-Ping, WANG Chun-Lin. A clinical follow-up study of premature thelarche in infants under two years of age[J]. Chinese Journal of Contemporary Pediatrics. 2013, 15(4): 285-288 https://doi.org/10.7499/j.issn.1008-8830.2013.04.010

参考文献

［1］朱顺叶,杜敏联,林爱华. 单纯性乳房早发育向完全性中枢性性早熟转化的相关因素分析［J］.中国实用儿科杂志，2008，23（3）：174-176.

［2］邹奕,方茜,程英,沈笑梅,黄安源,刘亚,等. 婴幼儿乳房早发育162例临床观察［J］.中国儿童保健杂志，2011,19（4）：363-364.

［3］Curfman AL, Reljanovic SM, McNelis KM, Dong TT, Lewis SA, Jackson LW,et al. Premature thelarche in infants and toddlers: prevalence, natural history and environmental determinants［J］. Pediatr Adolesc Gynecol, 2011, 24(6):338-341.

［4］Atay Z, Turan S, Guran T, Furman A, Bereket A. The prevalence and risk factors of premature thelarche and pubarche in 4-to 8-year-old girls［J］. Acta Paediatr, 2012, 101(2):e71-e75.

［5］Marshall WA, Tanner JM. Growth and physiological development during adolescence［J］. Annu Rev Med, 1968, 19:283.

［6］Elmlinger MW, Kuhnel W, Ranke MB. Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), estradiol (E2), prolactin, progesterone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), cortisol and ferritin in neonates, children and young adults［J］. Clin Chem Lab Med, 2002, 40(11):1151-1160.

［7］中华医学会儿科学分会内分泌遗传代谢组学. 中枢性（真性）性早熟诊治指南［J］. 中华儿科学杂志,2007,45(6):426-427.

［8］Ma HM, Du ML, Luo XP, Chen SK, Liu L, Chen RM, et al. Onset of breast and pubic hair development and menses in urban chinese girls［J］. Pediatrics, 2009, 124(2): 269-277.

［9］Aks glaede L, Srensen K, Petersen JH, Skakkebaek NE, Juul A. Recent decline in age at breast development: the Copenhagen Puberty Study［J］. Pediatrics, 2009, 123(5):932-939.

［10］郭友宁,吴敏伦,沈水仙. 上海市5岁内女童乳房早发育患病率及影响因素的分析［J］. 实用儿科临床杂志, 2002,17:49-52.

［11］Crofton PM, Evans NE, Wardhaugh B, Groome NP, Kelnar CJ. Evidence for increased ovarian follicular activity in girls with premature thelarche［J］. Clin Endocrinol (Oxf), 2005,62(2): 205-209.

［12］Chou YY, Huang PC, Lee CC, Wu MH, Lin SJ. Phthalate exposure in girls during early puberty［J］. J Pediatr Endocrinol Metab, 2009, 22(1): 69-77.

［13］Jurewicz J, Hanke W. Exposure to phthalates: reproductive outcome and children health. A review of epidemiological studies［J］. Int J Occup Med Environ Health, 2011, 24(2): 115-141.

［14］Massart F, Saggese G. Oestrogenic mycotoxin exposures and precocious pubertal development［J］. Int J Androl, 2010, 33(2): 369-376.

［15］Weng YI, Hsu PY, Liyanarachchi S, Liu J, Deatherage DE, Huang YW, et al. Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells［J］.Toxicol Appl Pharmacol, 2010, 248(2): 111-121.

［16］Fortes EM, Malerba MI, Luchini PD, Sugawara EK, Sumodjo L, Ribeiro Neto LM, et al. High intake of phytoestrogens and precocious thelarche: case report with a possible correlation［J］. Arq Bras Endocrinol Metabol, 2007, 51(3): 500-503.

［17］Klein KO, Mericq V, Brown-Dawson JM, Larmore KA, Cabezas P, Cortinez A. Estrogen levels in girls with premature thelarche compared with normal prepubertal girls as determined by an ultrasensitive recombinant cell bioassay［J］. J Pediatr,1999, 134(2): 190-192.

［18］de Vries L, Guz-Mark A, Lazar L, Reches A, Phillip M. Premature thelarche: age at presentation affects clinical course but not clinical characteristics or risk to progress to precocious puberty［J］. J Pediatr, 2010, 156(3): 466-471.

［19］Zhu SY, Du ML, Huang TT. An analysis of predictive factors for the conversion from premature thelarche into complete central precocious puberty［J］. J Pediatr Endocrinol Metab, 2008, 21（6）:533-538.